Allergan has acquired the SkinMedica skin care business for $350 million.
Allergan will also pay SkinMedica an additional $25 million contingent upon the acquired products achieving a specific level Inc’s topical-aesthetics of net sales. The acquisition, which is expected to close later this year, does not include the SkinMedica Colorescience aesthetic makeup line. SkinMedica will be spinning out the Colorescience business in connection with the closing of the acquisition.
“The acquisition of SkinMedica will nicely complement our existing facial aesthetics business, which includes products such as BOTOX